Gene Symbol | Gene ID | Gene Info |
---|---|---|
DUXA
|
ENSG00000258873.2 | double homeobox A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_57684363_57684522 | DUXA | 5631 | 0.134985 | 0.39 | 2.9e-01 | Click! |
chr19_57683645_57683950 | DUXA | 4986 | 0.139304 | -0.11 | 7.7e-01 | Click! |
chr19_57682857_57683287 | DUXA | 4261 | 0.146362 | 0.10 | 7.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_157749235_157750071 | 0.92 |
ENSG00000263848 |
. |
122116 |
0.06 |
chr14_86001323_86001474 | 0.81 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
4826 |
0.27 |
chr5_53753293_53753597 | 0.80 |
HSPB3 |
heat shock 27kDa protein 3 |
2000 |
0.44 |
chr16_54968513_54968925 | 0.80 |
IRX5 |
iroquois homeobox 5 |
2735 |
0.43 |
chr6_12573314_12573545 | 0.74 |
PHACTR1 |
phosphatase and actin regulator 1 |
144464 |
0.05 |
chr17_29888799_29888950 | 0.73 |
ENSG00000207614 |
. |
1859 |
0.19 |
chr5_24644888_24645378 | 0.70 |
CDH10 |
cadherin 10, type 2 (T2-cadherin) |
46 |
0.99 |
chr11_131780111_131780399 | 0.67 |
NTM |
neurotrimin |
642 |
0.77 |
chr2_38265076_38265999 | 0.66 |
RMDN2-AS1 |
RMDN2 antisense RNA 1 |
2053 |
0.33 |
chr15_37179413_37179956 | 0.66 |
ENSG00000212511 |
. |
34843 |
0.22 |
chr4_81192022_81192173 | 0.65 |
FGF5 |
fibroblast growth factor 5 |
4304 |
0.29 |
chr1_165665531_165665807 | 0.64 |
ALDH9A1 |
aldehyde dehydrogenase 9 family, member A1 |
1876 |
0.34 |
chr20_43970794_43971114 | 0.63 |
SDC4 |
syndecan 4 |
6110 |
0.13 |
chr4_86700524_86700675 | 0.62 |
ARHGAP24 |
Rho GTPase activating protein 24 |
740 |
0.76 |
chr8_49831086_49831370 | 0.62 |
SNAI2 |
snail family zinc finger 2 |
2760 |
0.41 |
chr5_111090218_111090459 | 0.62 |
NREP |
neuronal regeneration related protein |
1610 |
0.42 |
chr8_70406794_70407007 | 0.62 |
SULF1 |
sulfatase 1 |
1872 |
0.5 |
chr3_66139685_66140118 | 0.61 |
SLC25A26 |
solute carrier family 25 (S-adenosylmethionine carrier), member 26 |
20616 |
0.25 |
chr6_152701576_152701930 | 0.60 |
SYNE1-AS1 |
SYNE1 antisense RNA 1 |
72 |
0.97 |
chr17_67137246_67137397 | 0.58 |
ABCA6 |
ATP-binding cassette, sub-family A (ABC1), member 6 |
694 |
0.69 |
chr6_169653692_169653887 | 0.58 |
THBS2 |
thrombospondin 2 |
350 |
0.92 |
chr3_175389807_175390608 | 0.57 |
ENSG00000201648 |
. |
62940 |
0.12 |
chr5_102202832_102203172 | 0.57 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
1182 |
0.66 |
chr22_46462951_46463814 | 0.57 |
RP6-109B7.4 |
|
2389 |
0.16 |
chr3_149371362_149371801 | 0.56 |
WWTR1-AS1 |
WWTR1 antisense RNA 1 |
3226 |
0.2 |
chr9_21688149_21688723 | 0.55 |
ENSG00000244230 |
. |
10877 |
0.24 |
chr3_114343007_114343163 | 0.55 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
32 |
0.99 |
chr12_78336292_78336638 | 0.54 |
NAV3 |
neuron navigator 3 |
23591 |
0.28 |
chr20_56706361_56706780 | 0.54 |
C20orf85 |
chromosome 20 open reading frame 85 |
19390 |
0.21 |
chr1_68297324_68297475 | 0.54 |
GNG12-AS1 |
GNG12 antisense RNA 1 |
587 |
0.71 |
chr13_110957949_110958238 | 0.53 |
COL4A2 |
collagen, type IV, alpha 2 |
66 |
0.97 |
chr11_122072907_122073271 | 0.53 |
ENSG00000207994 |
. |
50073 |
0.12 |
chr21_32715523_32716836 | 0.53 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
415 |
0.91 |
chr2_65889672_65889956 | 0.53 |
ENSG00000265899 |
. |
4576 |
0.32 |
chr4_54213222_54213526 | 0.53 |
SCFD2 |
sec1 family domain containing 2 |
18854 |
0.21 |
chr7_93552303_93552503 | 0.52 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
1392 |
0.38 |
chr6_82707021_82707202 | 0.52 |
ENSG00000223044 |
. |
213046 |
0.02 |
chr10_124253467_124253937 | 0.52 |
HTRA1 |
HtrA serine peptidase 1 |
12505 |
0.2 |
chr1_33876024_33876604 | 0.52 |
PHC2 |
polyhomeotic homolog 2 (Drosophila) |
19902 |
0.15 |
chr5_16933613_16934070 | 0.52 |
MYO10 |
myosin X |
2206 |
0.34 |
chr2_164590053_164590372 | 0.52 |
FIGN |
fidgetin |
2305 |
0.48 |
chr7_6296963_6297114 | 0.51 |
CYTH3 |
cytohesin 3 |
15237 |
0.18 |
chr2_101437792_101437972 | 0.51 |
NPAS2 |
neuronal PAS domain protein 2 |
395 |
0.8 |
chr5_66254399_66254664 | 0.50 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
167 |
0.97 |
chr4_20290565_20290748 | 0.50 |
SLIT2 |
slit homolog 2 (Drosophila) |
34113 |
0.23 |
chr15_96878465_96878729 | 0.49 |
ENSG00000222651 |
. |
2107 |
0.24 |
chr5_180212623_180213033 | 0.49 |
CTC-205M6.5 |
|
2041 |
0.28 |
chr2_87551749_87551924 | 0.49 |
IGKV3OR2-268 |
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
13798 |
0.29 |
chr18_39486579_39486788 | 0.48 |
PIK3C3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
48488 |
0.2 |
chr12_118628413_118628612 | 0.48 |
TAOK3 |
TAO kinase 3 |
156 |
0.96 |
chr14_96671190_96671644 | 0.48 |
RP11-404P21.8 |
Uncharacterized protein |
236 |
0.48 |
chr15_49717786_49717937 | 0.47 |
FGF7 |
fibroblast growth factor 7 |
2404 |
0.35 |
chr11_114167265_114167463 | 0.47 |
NNMT |
nicotinamide N-methyltransferase |
721 |
0.72 |
chr6_169651321_169651472 | 0.46 |
THBS2 |
thrombospondin 2 |
850 |
0.72 |
chr2_157659750_157659995 | 0.46 |
ENSG00000263848 |
. |
211897 |
0.02 |
chr10_33620140_33620362 | 0.46 |
NRP1 |
neuropilin 1 |
3059 |
0.34 |
chr5_158488903_158489314 | 0.46 |
EBF1 |
early B-cell factor 1 |
37593 |
0.17 |
chr7_55141701_55142160 | 0.46 |
EGFR |
epidermal growth factor receptor |
35486 |
0.22 |
chr15_96897591_96898313 | 0.46 |
AC087477.1 |
Uncharacterized protein |
6535 |
0.18 |
chr16_4424352_4424847 | 0.46 |
VASN |
vasorin |
2750 |
0.17 |
chr3_112354153_112354320 | 0.46 |
CCDC80 |
coiled-coil domain containing 80 |
2708 |
0.34 |
chr4_166794189_166794587 | 0.46 |
TLL1 |
tolloid-like 1 |
22 |
0.99 |
chr5_6159531_6159707 | 0.45 |
ENSG00000221568 |
. |
47395 |
0.2 |
chr20_34463775_34463999 | 0.45 |
ENSG00000201221 |
. |
11694 |
0.14 |
chr13_95255061_95255225 | 0.45 |
GPR180 |
G protein-coupled receptor 180 |
986 |
0.56 |
chr5_149534173_149534381 | 0.45 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
913 |
0.52 |
chr1_224075422_224075812 | 0.45 |
TP53BP2 |
tumor protein p53 binding protein, 2 |
41943 |
0.17 |
chr2_113379593_113379854 | 0.45 |
SLC20A1 |
solute carrier family 20 (phosphate transporter), member 1 |
23711 |
0.15 |
chrX_65857072_65857466 | 0.45 |
EDA2R |
ectodysplasin A2 receptor |
1614 |
0.5 |
chr4_151600832_151601026 | 0.45 |
ENSG00000221235 |
. |
39911 |
0.19 |
chr3_88191159_88191414 | 0.45 |
ZNF654 |
zinc finger protein 654 |
3032 |
0.24 |
chr6_116550687_116550852 | 0.45 |
RP3-486I3.5 |
|
15122 |
0.15 |
chr17_38440207_38440497 | 0.44 |
CDC6 |
cell division cycle 6 |
3533 |
0.16 |
chr15_60684685_60685107 | 0.44 |
ANXA2 |
annexin A2 |
1400 |
0.54 |
chr5_97790939_97791149 | 0.44 |
ENSG00000223053 |
. |
183891 |
0.03 |
chr6_18053801_18053981 | 0.44 |
KIF13A |
kinesin family member 13A |
66037 |
0.11 |
chr12_8147555_8147963 | 0.44 |
ENSG00000206636 |
. |
18904 |
0.14 |
chr4_48701412_48701950 | 0.44 |
FRYL |
FRY-like |
18493 |
0.24 |
chr4_23890359_23890765 | 0.44 |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
1096 |
0.66 |
chr2_238321225_238321570 | 0.44 |
COL6A3 |
collagen, type VI, alpha 3 |
1394 |
0.45 |
chr1_98514169_98514606 | 0.44 |
ENSG00000225206 |
. |
2660 |
0.42 |
chr16_83847696_83847847 | 0.44 |
HSBP1 |
heat shock factor binding protein 1 |
6177 |
0.18 |
chr5_150153790_150154104 | 0.43 |
SMIM3 |
small integral membrane protein 3 |
3561 |
0.18 |
chr7_116141667_116142184 | 0.43 |
CAV2 |
caveolin 2 |
2091 |
0.24 |
chr17_78044749_78045392 | 0.43 |
CCDC40 |
coiled-coil domain containing 40 |
12346 |
0.15 |
chr7_128380705_128380856 | 0.43 |
CALU |
calumenin |
1322 |
0.31 |
chr11_111848673_111848997 | 0.43 |
DIXDC1 |
DIX domain containing 1 |
802 |
0.5 |
chrX_281313_281835 | 0.43 |
LINC00685 |
long intergenic non-protein coding RNA 685 |
151 |
0.97 |
chr2_3625481_3625934 | 0.42 |
ENSG00000252531 |
. |
2453 |
0.16 |
chr3_64172371_64172810 | 0.42 |
PRICKLE2-AS3 |
PRICKLE2 antisense RNA 3 |
630 |
0.74 |
chr10_69865396_69865547 | 0.42 |
MYPN |
myopalladin |
441 |
0.84 |
chr16_51573277_51573428 | 0.42 |
ENSG00000223168 |
. |
132122 |
0.06 |
chr4_122616322_122616745 | 0.42 |
ANXA5 |
annexin A5 |
1584 |
0.45 |
chr18_30310087_30311054 | 0.42 |
AC012123.1 |
Uncharacterized protein |
39188 |
0.17 |
chrX_11456470_11456766 | 0.42 |
ARHGAP6 |
Rho GTPase activating protein 6 |
10725 |
0.3 |
chr1_116314334_116314544 | 0.42 |
CASQ2 |
calsequestrin 2 (cardiac muscle) |
3037 |
0.34 |
chr7_13985407_13985644 | 0.41 |
ETV1 |
ets variant 1 |
40541 |
0.2 |
chr2_203880731_203880966 | 0.41 |
NBEAL1 |
neurobeachin-like 1 |
1246 |
0.53 |
chr3_64674138_64674393 | 0.41 |
ADAMTS9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
589 |
0.78 |
chr3_73672725_73672876 | 0.41 |
PDZRN3-AS1 |
PDZRN3 antisense RNA 1 |
81 |
0.96 |
chr12_62998637_62998788 | 0.41 |
ENSG00000199179 |
. |
1246 |
0.3 |
chr17_45698884_45699286 | 0.41 |
NPEPPS |
aminopeptidase puromycin sensitive |
3369 |
0.19 |
chr8_107071752_107071924 | 0.41 |
ENSG00000251003 |
. |
833 |
0.76 |
chr5_57368325_57368559 | 0.41 |
ENSG00000238899 |
. |
2427 |
0.45 |
chr5_144624994_144625233 | 0.41 |
ENSG00000221467 |
. |
47775 |
0.2 |
chr14_89020333_89020536 | 0.40 |
PTPN21 |
protein tyrosine phosphatase, non-receptor type 21 |
643 |
0.64 |
chr7_92381446_92381634 | 0.40 |
ENSG00000206763 |
. |
50412 |
0.14 |
chr7_95402477_95402695 | 0.40 |
DYNC1I1 |
dynein, cytoplasmic 1, intermediate chain 1 |
670 |
0.81 |
chr2_44843789_44843940 | 0.40 |
ENSG00000252896 |
. |
165405 |
0.04 |
chr11_131782264_131782415 | 0.40 |
NTM |
neurotrimin |
977 |
0.63 |
chr8_24867792_24867943 | 0.40 |
CTD-2168K21.2 |
|
53732 |
0.14 |
chr9_124846791_124846942 | 0.40 |
TTLL11 |
tubulin tyrosine ligase-like family, member 11 |
9019 |
0.2 |
chr7_98970111_98970529 | 0.40 |
ARPC1B |
actin related protein 2/3 complex, subunit 1B, 41kDa |
1552 |
0.28 |
chr3_115596359_115596545 | 0.40 |
ENSG00000243359 |
. |
39737 |
0.22 |
chrY_231310_231809 | 0.40 |
NA |
NA |
> 106 |
NA |
chr8_13132829_13133895 | 0.40 |
DLC1 |
deleted in liver cancer 1 |
693 |
0.78 |
chr7_94029901_94030156 | 0.40 |
COL1A2 |
collagen, type I, alpha 2 |
6155 |
0.29 |
chr7_55509277_55509428 | 0.40 |
VOPP1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
74418 |
0.1 |
chr2_235862821_235863118 | 0.39 |
SH3BP4 |
SH3-domain binding protein 4 |
2249 |
0.48 |
chr5_34486658_34486809 | 0.39 |
RAI14 |
retinoic acid induced 14 |
169609 |
0.03 |
chr3_192288719_192288870 | 0.39 |
ENSG00000238902 |
. |
36893 |
0.17 |
chr2_3626466_3626991 | 0.39 |
ENSG00000252531 |
. |
1432 |
0.27 |
chr15_57510230_57510387 | 0.39 |
TCF12 |
transcription factor 12 |
1320 |
0.57 |
chr4_108817732_108818165 | 0.39 |
SGMS2 |
sphingomyelin synthase 2 |
2544 |
0.25 |
chr9_133656541_133656767 | 0.39 |
ABL1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
53799 |
0.13 |
chr5_52333250_52333558 | 0.39 |
CTD-2175A23.1 |
|
47296 |
0.12 |
chr17_5085116_5085307 | 0.39 |
ZNF594 |
zinc finger protein 594 |
2481 |
0.2 |
chr13_38172411_38172686 | 0.39 |
POSTN |
periostin, osteoblast specific factor |
315 |
0.95 |
chr6_1613704_1614304 | 0.39 |
FOXC1 |
forkhead box C1 |
3323 |
0.37 |
chr7_13960202_13960381 | 0.39 |
ETV1 |
ets variant 1 |
65775 |
0.14 |
chr9_113680727_113680998 | 0.39 |
ENSG00000206923 |
. |
15245 |
0.21 |
chr3_98616068_98616219 | 0.39 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
3872 |
0.21 |
chr8_119963118_119963285 | 0.39 |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
1238 |
0.55 |
chr2_228028292_228028853 | 0.39 |
COL4A4 |
collagen, type IV, alpha 4 |
257 |
0.8 |
chr1_217263352_217263815 | 0.38 |
ESRRG |
estrogen-related receptor gamma |
607 |
0.86 |
chr19_47693302_47693593 | 0.38 |
ENSG00000265134 |
. |
36752 |
0.11 |
chr2_110538678_110538908 | 0.38 |
RGPD5 |
RANBP2-like and GRIP domain containing 5 |
11542 |
0.27 |
chr21_38035564_38035846 | 0.38 |
SIM2 |
single-minded family bHLH transcription factor 2 |
35729 |
0.16 |
chr9_96902091_96902301 | 0.38 |
ENSG00000199165 |
. |
36038 |
0.13 |
chr19_13906290_13907522 | 0.38 |
ZSWIM4 |
zinc finger, SWIM-type containing 4 |
632 |
0.39 |
chr8_49831970_49832121 | 0.38 |
SNAI2 |
snail family zinc finger 2 |
1943 |
0.49 |
chr10_4284780_4284931 | 0.38 |
ENSG00000207124 |
. |
272289 |
0.02 |
chr7_94029074_94029225 | 0.38 |
COL1A2 |
collagen, type I, alpha 2 |
5276 |
0.3 |
chr4_129292742_129292893 | 0.38 |
PGRMC2 |
progesterone receptor membrane component 2 |
82833 |
0.11 |
chr7_18550262_18550413 | 0.38 |
HDAC9 |
histone deacetylase 9 |
1401 |
0.57 |
chr2_9348603_9349207 | 0.37 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
2011 |
0.46 |
chr7_93925885_93926036 | 0.37 |
COL1A2 |
collagen, type I, alpha 2 |
97913 |
0.08 |
chr12_95597108_95597270 | 0.37 |
FGD6 |
FYVE, RhoGEF and PH domain containing 6 |
13966 |
0.18 |
chr22_35778076_35778227 | 0.37 |
HMOX1 |
heme oxygenase (decycling) 1 |
1323 |
0.43 |
chr13_24121751_24121902 | 0.37 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
22683 |
0.26 |
chr17_2075729_2075982 | 0.37 |
SMG6 |
SMG6 nonsense mediated mRNA decay factor |
617 |
0.64 |
chr1_47778566_47778731 | 0.37 |
STIL |
SCL/TAL1 interrupting locus |
159 |
0.95 |
chr8_37556496_37556710 | 0.37 |
ZNF703 |
zinc finger protein 703 |
3334 |
0.17 |
chr18_10455593_10455868 | 0.37 |
APCDD1 |
adenomatosis polyposis coli down-regulated 1 |
751 |
0.75 |
chr3_111480072_111480300 | 0.37 |
PHLDB2 |
pleckstrin homology-like domain, family B, member 2 |
28842 |
0.2 |
chr7_78399800_78400051 | 0.36 |
MAGI2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
471 |
0.9 |
chr1_238753523_238753674 | 0.36 |
ENSG00000252371 |
. |
264510 |
0.02 |
chr10_32097535_32097689 | 0.36 |
ARHGAP12 |
Rho GTPase activating protein 12 |
45496 |
0.17 |
chr2_36583449_36584760 | 0.36 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
490 |
0.89 |
chr3_126113468_126113707 | 0.36 |
RP11-71E19.5 |
|
107 |
0.63 |
chr20_19957293_19957444 | 0.36 |
NAA20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
40392 |
0.16 |
chr7_47640510_47640989 | 0.36 |
TNS3 |
tensin 3 |
18593 |
0.25 |
chr22_25348691_25349626 | 0.36 |
KIAA1671 |
KIAA1671 |
461 |
0.83 |
chr4_77704559_77704807 | 0.36 |
RP11-359D14.3 |
|
18434 |
0.19 |
chr22_39801646_39801840 | 0.36 |
TAB1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
5954 |
0.16 |
chr4_120614315_120614472 | 0.36 |
PDE5A |
phosphodiesterase 5A, cGMP-specific |
64247 |
0.13 |
chr1_226521053_226521239 | 0.35 |
ENSG00000239094 |
. |
17281 |
0.16 |
chr13_44404357_44404508 | 0.35 |
ENOX1 |
ecto-NOX disulfide-thiol exchanger 1 |
43388 |
0.15 |
chr16_53086342_53086851 | 0.35 |
RP11-467J12.4 |
|
189 |
0.95 |
chr3_185825097_185825248 | 0.35 |
ETV5 |
ets variant 5 |
1161 |
0.55 |
chr17_79315981_79316442 | 0.35 |
TMEM105 |
transmembrane protein 105 |
11737 |
0.13 |
chr19_47366981_47367578 | 0.35 |
AP2S1 |
adaptor-related protein complex 2, sigma 1 subunit |
13030 |
0.17 |
chr16_3241653_3241969 | 0.35 |
AJ003147.9 |
|
3599 |
0.12 |
chrX_133681520_133681671 | 0.35 |
ENSG00000223749 |
. |
854 |
0.38 |
chr2_189846006_189846157 | 0.35 |
ENSG00000221502 |
. |
3263 |
0.28 |
chr8_93107061_93107485 | 0.35 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
170 |
0.98 |
chr10_10872293_10872444 | 0.35 |
CELF2 |
CUGBP, Elav-like family member 2 |
174891 |
0.03 |
chr15_90197878_90198651 | 0.35 |
KIF7 |
kinesin family member 7 |
418 |
0.77 |
chr5_54455785_54456014 | 0.35 |
GPX8 |
glutathione peroxidase 8 (putative) |
47 |
0.96 |
chr1_61550818_61550969 | 0.35 |
ENSG00000263380 |
. |
1691 |
0.36 |
chr8_62623308_62623479 | 0.35 |
ASPH |
aspartate beta-hydroxylase |
3691 |
0.27 |
chr4_126289975_126290162 | 0.35 |
ENSG00000201297 |
. |
6094 |
0.28 |
chr20_11524560_11524790 | 0.35 |
ENSG00000222281 |
. |
275064 |
0.02 |
chr15_89533182_89533333 | 0.35 |
ENSG00000265866 |
. |
17574 |
0.2 |
chr3_58258156_58258366 | 0.35 |
RPP14 |
ribonuclease P/MRP 14kDa subunit |
33728 |
0.14 |
chr11_107881564_107881715 | 0.35 |
CUL5 |
cullin 5 |
2180 |
0.34 |
chr5_98107570_98107721 | 0.35 |
RGMB-AS1 |
RGMB antisense RNA 1 |
837 |
0.59 |
chr4_153272766_153273041 | 0.35 |
FBXW7 |
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
1220 |
0.52 |
chr9_16867910_16868386 | 0.34 |
BNC2 |
basonuclin 2 |
2556 |
0.42 |
chr11_122045636_122045787 | 0.34 |
ENSG00000207994 |
. |
22695 |
0.16 |
chr2_197831476_197831662 | 0.34 |
ANKRD44 |
ankyrin repeat domain 44 |
33657 |
0.18 |
chr14_53416235_53416562 | 0.34 |
FERMT2 |
fermitin family member 2 |
888 |
0.69 |
chr1_202508681_202509081 | 0.34 |
ENSG00000253042 |
. |
12326 |
0.21 |
chr12_15490173_15490332 | 0.34 |
RERG |
RAS-like, estrogen-regulated, growth inhibitor |
11280 |
0.23 |
chr6_21886579_21886878 | 0.34 |
ENSG00000222515 |
. |
199045 |
0.03 |
chr10_92679821_92679972 | 0.34 |
ANKRD1 |
ankyrin repeat domain 1 (cardiac muscle) |
1137 |
0.46 |
chr9_35907347_35908019 | 0.34 |
HRCT1 |
histidine rich carboxyl terminus 1 |
1494 |
0.3 |
chr3_170625035_170625186 | 0.34 |
EIF5A2 |
eukaryotic translation initiation factor 5A2 |
1277 |
0.5 |
chr3_57545487_57545638 | 0.34 |
PDE12 |
phosphodiesterase 12 |
3558 |
0.13 |
chr7_42974061_42974212 | 0.34 |
PSMA2 |
proteasome (prosome, macropain) subunit, alpha type, 2 |
2314 |
0.27 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.6 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.2 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.1 | 0.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.6 | GO:0014029 | neural crest formation(GO:0014029) neural crest cell fate commitment(GO:0014034) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.4 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.7 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.4 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.2 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0031223 | auditory behavior(GO:0031223) |
0.1 | 0.2 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.3 | GO:0010665 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.2 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.2 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.5 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.1 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.0 | 0.5 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.2 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0051940 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 0.1 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.0 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.0 | 0.2 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.4 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.1 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.2 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.0 | 2.0 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.4 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.4 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0061217 | regulation of mesonephros development(GO:0061217) regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0071501 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.2 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.1 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.0 | 0.5 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
0.0 | 0.1 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.8 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.0 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.2 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.0 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.1 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0090037 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.0 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.0 | 0.0 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0071883 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.0 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.0 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.2 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.0 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.3 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 1.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.6 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.4 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.4 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 2.9 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 1.3 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 1.5 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 4.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.2 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.8 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.7 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.4 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.5 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.3 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 2.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 1.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 2.0 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.0 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.0 | 0.0 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 3.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 2.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 1.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 2.6 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.0 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |